3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Leukemia
12
Breast Neoplasms
9
Neoplastic Cells, Circulating
7
Prostatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Multiple Myeloma
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Wilms Tumor
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms, Plasma Cell
3
Kidney Neoplasms
3
Congenital Abnormalities
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Intraductal, Noninfiltrating
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms, Male
2
Adenocarcinoma Of Esophagus
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Interventions
Oxaliplatin
14
Fluorouracil
11
Capecitabine
9
Surveys and Questionnaires
8
Leucovorin
8
Irinotecan
8
Cisplatin
8
Bevacizumab
8
Standard of Care
5
Gemcitabine
5
Drug Therapy
4
S 1 (combination)
3
Radiotherapy
3
Nivolumab
3
Interviews as Topic
3
IFL protocol
3
Educational Status
3
Cyclophosphamide
3
Colonoscopy
3
Blood Specimen Collection
3
5,10-methylenetetrahydrofolic acid
3
trebananib
2
tivozanib
2
pembrolizumab
2
Taxes
2
Remote Patient Monitoring
2
Pemetrexed
2
Panitumumab
2
Ocoxin
2
N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gastrointestinal Neoplasms
×
Reverse Transcriptase Polymerase Chain Reaction
×
Clear all
NCT04379232
2020-05-07
SurgiCovid
Hospices Civils de Lyon
Completed
112 enrolled